Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Finasteride treatment makes the prostate look more like a healthy one.

BPH is common in older men and often occurs with other age-related health issues.

These medications for BPH have known risks and may have new side effects.

Erectile dysfunction is linked to marital issues in patients with benign prostatic hyperplasia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Ultrasound and color Doppler can help diagnose and decide treatment for early puberty in young girls.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Men with better urinary symptoms have a lower risk of death.